Skip to main content
Erschienen in: Heart and Vessels 9/2021

19.03.2021 | Original Article

Lesion size and adjacent tissue damage assessment with high power and short duration radiofrequency ablation: comparison to conventional radiofrequency ablation power setting

verfasst von: Yoshinari Enomoto, Keijiro Nakamura, Rina Ishii, Yasutake Toyoda, Masako Asami, Takahito Takagi, Hikari Hashimoto, Hidehiko Hara, Kaoru Sugi, Masao Moroi, Masato Nakamura

Erschienen in: Heart and Vessels | Ausgabe 9/2021

Einloggen, um Zugang zu erhalten

Abstract

There is increased interest in creating high-power short duration (HPSD) ablation lesions in the field of atrial fibrillation (AF) radiofrequency ablation (RFA). We evaluated the lesion characteristics and collateral damage using two separate RFA protocols setting (HPSD: 50 W and 7 s vs control: 25 W and 30 s) in vitro model. Sixteen freshly killed porcine hearts were obtained, and the atrium and ventricle slabs were harvested for ablation. The each slabs were placed in a tissue bath with circulating 0.9% NaCl at maintained temperature 37 °C. RFA was performed with 4 mm tip irrigated force sensing catheter. All lesions were ablated under recording the electrical parameters using with Ensite Navx system (St. Jude Medical, St. Paul, Minnesota). After RFA, lesion characteristics were assessed for each lesion. Thirty-five lesions were made for each ablation protocol (total 70 lesions for analysis). Ablation parameters were similar between two groups (HPSD vs control; impedance drop (Ω): 34.2 ± 13.1 vs 36.1 ± 8.65 P = 0.49, contact force (g): 13.9 ± 4.37 vs 14.6 ± 5.09, P = 0.51, lesion size index: 4.8 ± 0.52 vs 4.73 ± 0.59, P = 0.62). Although the lesion volume was similar, the HPSD ablation creates wider but more shallower lesions compared to control group (HPSD vs control; lesion volume: 29.6 ± 18.1 mm3 vs 35.5 ± 17.1 mm3 P = 0.16, lesion diameter: 4.98 ± 0.91 mm vs 4.45 ± 0.74 mm P = 0.0095, lesion depth: 2.2 ± 0.76 mm vs 2.8 ± 1.56 mm P = 0.046). Of these, 38 lesions were assessed for adjacent tissue damage and adjacent tissue damages were more frequent seen in control group (HPSD vs control; 1/19 (5.26%) vs 6/19 (31.5%), P = 0.036). Effective lesions were made with HPSD, thereby reducing RFA procedure time. Although the lesion volume was similar between two groups, collateral damage was less seen in HPSD group attributed by lesion characteristics.
Literatur
2.
Zurück zum Zitat Iso K, Nagashima K, Arai M, Watanabe R, Yokoyama K, Matsumoto N, Otsuka T, Suzuki S, Hirata A, Murakami M, Takami M, Kimura M, Fukaya H, Nakahara S, Kato T, Hayashi H, Iwasaki YK, Shimizu W, Nakajima I, Harada T, Koyama J, Okumura K, Tokuda M, Yamane T, Tanimoto K, Momiyama Y, Nonoguchi N, Soejima K, Ejima K, Hagiwara N, Harada M, Sonoda K, Inoue M, Kumagai K, Hayashi H, Yazaki Y, Satomi K, Watari Y, Okumura Y, AF Ablation Frontier Registry Investigators (2020) Clinical outcomes of ablation versus non-ablation therapy for atrial fibrillation in Japan: analysis of pooled data from the AF Frontier Ablation Registry and SAKURA AF Registry. Heart Vessels. https://doi.org/10.1007/s00380-020-01721-xCrossRefPubMed Iso K, Nagashima K, Arai M, Watanabe R, Yokoyama K, Matsumoto N, Otsuka T, Suzuki S, Hirata A, Murakami M, Takami M, Kimura M, Fukaya H, Nakahara S, Kato T, Hayashi H, Iwasaki YK, Shimizu W, Nakajima I, Harada T, Koyama J, Okumura K, Tokuda M, Yamane T, Tanimoto K, Momiyama Y, Nonoguchi N, Soejima K, Ejima K, Hagiwara N, Harada M, Sonoda K, Inoue M, Kumagai K, Hayashi H, Yazaki Y, Satomi K, Watari Y, Okumura Y, AF Ablation Frontier Registry Investigators (2020) Clinical outcomes of ablation versus non-ablation therapy for atrial fibrillation in Japan: analysis of pooled data from the AF Frontier Ablation Registry and SAKURA AF Registry. Heart Vessels. https://​doi.​org/​10.​1007/​s00380-020-01721-xCrossRefPubMed
3.
Zurück zum Zitat Reddy VY, Shah DC, Kautzner J, Schmidt B, Saoudi N, Herrera C, Jaïs P, Hindricks G, Peichl P, Yulzari A, Lambert H, Neuzil P, Natale A, Kuck KH (2012) The relationship between contact force and clinical outcome during radiofrequency catheter ablation of atrial fibrillation in the TOCCATA study. Heart Rhythm 9:1789–1795CrossRef Reddy VY, Shah DC, Kautzner J, Schmidt B, Saoudi N, Herrera C, Jaïs P, Hindricks G, Peichl P, Yulzari A, Lambert H, Neuzil P, Natale A, Kuck KH (2012) The relationship between contact force and clinical outcome during radiofrequency catheter ablation of atrial fibrillation in the TOCCATA study. Heart Rhythm 9:1789–1795CrossRef
4.
Zurück zum Zitat Nath S, Redick JA, Whayne JG, Haines DE (1994) Ultrastructural observations in the myocardium beyond the region of acute coagulation necrosis following radiofrequency catheter ablation. J Cardiovasc Electrophysiol 5:838–845CrossRef Nath S, Redick JA, Whayne JG, Haines DE (1994) Ultrastructural observations in the myocardium beyond the region of acute coagulation necrosis following radiofrequency catheter ablation. J Cardiovasc Electrophysiol 5:838–845CrossRef
5.
Zurück zum Zitat Yokoyama K, Nakagawa H, Shah DC, Lambert H, Leo G, Aeby N, Ikeda A, Pitha JV, Sharma T, Lazzara R, Jackmanet WM (2008) Novel contact force sensor incorporated in irrigated radiofrequency ablation catheter predicts lesion size and incidence of steam pop and thrombus. Circ Arrhythm Electrophysiol 1:354–362CrossRef Yokoyama K, Nakagawa H, Shah DC, Lambert H, Leo G, Aeby N, Ikeda A, Pitha JV, Sharma T, Lazzara R, Jackmanet WM (2008) Novel contact force sensor incorporated in irrigated radiofrequency ablation catheter predicts lesion size and incidence of steam pop and thrombus. Circ Arrhythm Electrophysiol 1:354–362CrossRef
6.
Zurück zum Zitat Natale A, Reddy VY, Monir G, Wilber DJ, Lindsay BD, McElderry HT, Kantipudi C, Mansour MC, Melby DP, Packer DL, Nakagawa H, Zhang B, Stagg RB, Boo LM, Marchlinski FE (2014) Paroxysmal AF catheter ablation with a contact force sensing catheter: results of the prospective, multicenter SMART-AF trial. J Am Coll Cardiol 64:647–656CrossRef Natale A, Reddy VY, Monir G, Wilber DJ, Lindsay BD, McElderry HT, Kantipudi C, Mansour MC, Melby DP, Packer DL, Nakagawa H, Zhang B, Stagg RB, Boo LM, Marchlinski FE (2014) Paroxysmal AF catheter ablation with a contact force sensing catheter: results of the prospective, multicenter SMART-AF trial. J Am Coll Cardiol 64:647–656CrossRef
7.
Zurück zum Zitat Reddy VY, Grimaldi M, Potter TD, Vijgen JM, Bulava A, Duytschaever MF, Martinek M, Natale A, Knecht S, Neuzil P, Pürerfellner H (2019) Pulmonary vein isolation with very high power, short duration, temperature-controlled lesions: the QDOT-FAST trial. JACC Clin Electrophysiol 5:778–786CrossRef Reddy VY, Grimaldi M, Potter TD, Vijgen JM, Bulava A, Duytschaever MF, Martinek M, Natale A, Knecht S, Neuzil P, Pürerfellner H (2019) Pulmonary vein isolation with very high power, short duration, temperature-controlled lesions: the QDOT-FAST trial. JACC Clin Electrophysiol 5:778–786CrossRef
8.
Zurück zum Zitat Winkle RA, Moskovitz R, Hardwin Mead R, Engel G, Kong MH, Fleming W, Salcedo J, Patrawala RA, Tranter JH, Shai I (2018) Atrial fibrillation ablation using very short duration 50 W ablations and contact force sensing catheter. J Interv Card Electrophysiol 52:1–8CrossRef Winkle RA, Moskovitz R, Hardwin Mead R, Engel G, Kong MH, Fleming W, Salcedo J, Patrawala RA, Tranter JH, Shai I (2018) Atrial fibrillation ablation using very short duration 50 W ablations and contact force sensing catheter. J Interv Card Electrophysiol 52:1–8CrossRef
9.
Zurück zum Zitat Bhaskaran A, Chik W, Pouliopoulos J, Nalliah C, Qian P, Barry T, Nadri F, Samanta R, Tran Y, Thomas S, Kovoor P, Thiagalingam A (2017) Five seconds of 50–60 W radio frequency atrial ablations were transmural and safe: an in vitro mechanistic assessment and force-controlled in vivo validation. Europace 19:874–880PubMed Bhaskaran A, Chik W, Pouliopoulos J, Nalliah C, Qian P, Barry T, Nadri F, Samanta R, Tran Y, Thomas S, Kovoor P, Thiagalingam A (2017) Five seconds of 50–60 W radio frequency atrial ablations were transmural and safe: an in vitro mechanistic assessment and force-controlled in vivo validation. Europace 19:874–880PubMed
10.
Zurück zum Zitat Leshem E, Zilberman I, Tschabrunn CM, Barkagan M, Contreras-Valdes FM, Govari A, Anter E (2018) High-power and short-duration ablation for pulmonary vein isolation: biophysical characterization. JACC Clin Electrophysiol 4:467–479CrossRef Leshem E, Zilberman I, Tschabrunn CM, Barkagan M, Contreras-Valdes FM, Govari A, Anter E (2018) High-power and short-duration ablation for pulmonary vein isolation: biophysical characterization. JACC Clin Electrophysiol 4:467–479CrossRef
11.
Zurück zum Zitat Kautzner J, Neuzil P, Lambert H, Peichl P, Petru J, Cihak R, Skoda J, Wichterle D, Wissner E, Yulzari A, Kuck KH (2015) EFFICUS II: optimization of catheter contact force improves outcome of pulmonary vein isolation for paroxysmal atrial fibrillation. Europace 17:1229–1235CrossRef Kautzner J, Neuzil P, Lambert H, Peichl P, Petru J, Cihak R, Skoda J, Wichterle D, Wissner E, Yulzari A, Kuck KH (2015) EFFICUS II: optimization of catheter contact force improves outcome of pulmonary vein isolation for paroxysmal atrial fibrillation. Europace 17:1229–1235CrossRef
12.
Zurück zum Zitat Wittkampf FHM, Nakagawa H, Forestu S, Aoyama H, Jackman WM (2005) Saline-irrigated radiofrequency ablation electrode with external cooling. J Cardiovasc Electrophysiol 16:323–328CrossRef Wittkampf FHM, Nakagawa H, Forestu S, Aoyama H, Jackman WM (2005) Saline-irrigated radiofrequency ablation electrode with external cooling. J Cardiovasc Electrophysiol 16:323–328CrossRef
13.
Zurück zum Zitat Kuck KH, Brugada J, Fürnkranz A, Metzner A, Ouyang F, Chun KR, Elvan A, Arentz T, Bestehorn K, Pocock SJ, Albenque JP, Tondo C, FIREANDICE Investigators (2016) Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation. N Engl J Med 374:2235–2245CrossRef Kuck KH, Brugada J, Fürnkranz A, Metzner A, Ouyang F, Chun KR, Elvan A, Arentz T, Bestehorn K, Pocock SJ, Albenque JP, Tondo C, FIREANDICE Investigators (2016) Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation. N Engl J Med 374:2235–2245CrossRef
14.
Zurück zum Zitat Takamiya T, Nitta J, Inaba O, Sato A, Inamura Y, Kato N, Murata K, Ikenouchi T, Kono T, Nitta G, Matsumura Y, Takahashi Y, Goya M, Sasano T (2020) Cryoballoon versus radiofrequency ablation for paroxysmal atrial fibrillation in hemodialysis patients. Heart Vessels 35:1709–1716CrossRef Takamiya T, Nitta J, Inaba O, Sato A, Inamura Y, Kato N, Murata K, Ikenouchi T, Kono T, Nitta G, Matsumura Y, Takahashi Y, Goya M, Sasano T (2020) Cryoballoon versus radiofrequency ablation for paroxysmal atrial fibrillation in hemodialysis patients. Heart Vessels 35:1709–1716CrossRef
15.
Zurück zum Zitat Patel PJ, Padanilam BJ (2018) High-power short-duration ablation: better, safer, and faster? J Cardiovasc Electrophysiol 29:1576–1577CrossRef Patel PJ, Padanilam BJ (2018) High-power short-duration ablation: better, safer, and faster? J Cardiovasc Electrophysiol 29:1576–1577CrossRef
16.
Zurück zum Zitat Ho SY, Sanchez-Quintana D, Cabrera JA, Anderson RH (1999) Anatomy of the left atrium: implications for radiofrequency ablation of atrial fibrillation. J Cardiovasc Electrophysiol 10:1525–1533CrossRef Ho SY, Sanchez-Quintana D, Cabrera JA, Anderson RH (1999) Anatomy of the left atrium: implications for radiofrequency ablation of atrial fibrillation. J Cardiovasc Electrophysiol 10:1525–1533CrossRef
17.
Zurück zum Zitat Sanchez-Quintana D, Cabrera JA, Climent V, Farre J, Mendonca MC, Ho SY (2005) Anatomic relations between the esophagus ane left atrium and relevance for ablation of atrial fibrillation. Circulation 112:1400–1405CrossRef Sanchez-Quintana D, Cabrera JA, Climent V, Farre J, Mendonca MC, Ho SY (2005) Anatomic relations between the esophagus ane left atrium and relevance for ablation of atrial fibrillation. Circulation 112:1400–1405CrossRef
18.
Zurück zum Zitat Beinart R, Abbara S, Blum A, Ferencik M, Heist K, Ruskin J, Mansour M (2011) Left atrial wall thickness variability measured by CT scans in patients undergoing pulmonary vein isolation. J Cardiovasc Electrophysiol 22:1232–1236CrossRef Beinart R, Abbara S, Blum A, Ferencik M, Heist K, Ruskin J, Mansour M (2011) Left atrial wall thickness variability measured by CT scans in patients undergoing pulmonary vein isolation. J Cardiovasc Electrophysiol 22:1232–1236CrossRef
19.
Zurück zum Zitat Borne RT, Sauer WH, Zipse MM, Zheng L, Tzou W, Nguyen DT (2018) Longer duration versus increasing power during radiofrequency ablation yields different ablation lesion characteristics. JACC Clin Electrophysiol 4:902–908CrossRef Borne RT, Sauer WH, Zipse MM, Zheng L, Tzou W, Nguyen DT (2018) Longer duration versus increasing power during radiofrequency ablation yields different ablation lesion characteristics. JACC Clin Electrophysiol 4:902–908CrossRef
20.
Zurück zum Zitat Whitaker J, Fish J, Harrison J, Chubb H, Williams SE, Fastl T, Corrado C, Van Zaen J, Gibbs J, O’Neill L, Mukherjee R, Rittey D, Thorsten J, Donskoy E, Sohal M, Rajani R, Niederer S, Wright M, O’Neill MD (2018) Lesion index-guided ablation facilitates continuous, transmural, and durable lesions in a porcine recovery model. Circ Arrhythm Electrophysiol 11(4):e005892CrossRef Whitaker J, Fish J, Harrison J, Chubb H, Williams SE, Fastl T, Corrado C, Van Zaen J, Gibbs J, O’Neill L, Mukherjee R, Rittey D, Thorsten J, Donskoy E, Sohal M, Rajani R, Niederer S, Wright M, O’Neill MD (2018) Lesion index-guided ablation facilitates continuous, transmural, and durable lesions in a porcine recovery model. Circ Arrhythm Electrophysiol 11(4):e005892CrossRef
21.
Zurück zum Zitat Kanamori N, Kato T, Sakagami S, Saeki T, Kato C, Kawai K, Chikata A, Takashima SI, Murai H, Usui S, Furusho H, Kaneko S, Takamura M (2018) Optimal lesion size index to prevent conduction gap during pulmonary vein isolation. J Cardiovasc Electrophysiol 29:1616–1623CrossRef Kanamori N, Kato T, Sakagami S, Saeki T, Kato C, Kawai K, Chikata A, Takashima SI, Murai H, Usui S, Furusho H, Kaneko S, Takamura M (2018) Optimal lesion size index to prevent conduction gap during pulmonary vein isolation. J Cardiovasc Electrophysiol 29:1616–1623CrossRef
22.
Zurück zum Zitat Cappato R, Calkins H, Chen SA, Davies W, Iesaka Y, Kalman J, Kim YH, Klein G, Natale A, Packer D, Skanes A, Ambrogi F, Biganzoli E (2010) Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol 3:32–38CrossRef Cappato R, Calkins H, Chen SA, Davies W, Iesaka Y, Kalman J, Kim YH, Klein G, Natale A, Packer D, Skanes A, Ambrogi F, Biganzoli E (2010) Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol 3:32–38CrossRef
23.
Zurück zum Zitat Ghia KK, Chugh A, Good E, Pelosi F, Jongnarangsin K, Bogun F, Morady F, Oral H (2009) A nationwide survey on the prevalence of atrioesophageal fistula after left atrial radiofrequency catheter ablation. J Interv Card Electrophysiol 24:33–36CrossRef Ghia KK, Chugh A, Good E, Pelosi F, Jongnarangsin K, Bogun F, Morady F, Oral H (2009) A nationwide survey on the prevalence of atrioesophageal fistula after left atrial radiofrequency catheter ablation. J Interv Card Electrophysiol 24:33–36CrossRef
24.
Zurück zum Zitat Leo M, Pedersen M, Rajappan K, Ginks MR, Hunter RJ, Bowers R, Kalla M, Bashir Y, Betts TR (2020) Power, lesion size index and oesophageal temperature alerts during atrial fibrillation ablation: a randomized study. Circ Arrhythm Electrophysiol 13(10):e008316CrossRef Leo M, Pedersen M, Rajappan K, Ginks MR, Hunter RJ, Bowers R, Kalla M, Bashir Y, Betts TR (2020) Power, lesion size index and oesophageal temperature alerts during atrial fibrillation ablation: a randomized study. Circ Arrhythm Electrophysiol 13(10):e008316CrossRef
25.
Zurück zum Zitat Piringer R, Deneke T, Foldyna B, Sonne K, Nentwich K, Ene E, Barth S, Lüsebrink U, Berkovitz A, Halbfass P (2021) Incidence of ablation-induced esophageal injury associated with high-power short duration temperature-controlled pulmonary vein isolation using a specialized open-irrigated ablation catheter: a retrospective single-center study. J Cardiovasc Electrophysiol. https://doi.org/10.1111/jce.14883CrossRefPubMed Piringer R, Deneke T, Foldyna B, Sonne K, Nentwich K, Ene E, Barth S, Lüsebrink U, Berkovitz A, Halbfass P (2021) Incidence of ablation-induced esophageal injury associated with high-power short duration temperature-controlled pulmonary vein isolation using a specialized open-irrigated ablation catheter: a retrospective single-center study. J Cardiovasc Electrophysiol. https://​doi.​org/​10.​1111/​jce.​14883CrossRefPubMed
26.
Zurück zum Zitat Calzolari V, De Mattia L, Indiani S, Crosato M, Furlanetto A, Licciardello C, Squasi PAM, Olivari Z (2017) In vitro validation of the lesion size index to predict lesion width and depth after irrigated radiofrequency ablation in a porcine model. JACC Clin Electrophysiol 3(10):1126–1135CrossRef Calzolari V, De Mattia L, Indiani S, Crosato M, Furlanetto A, Licciardello C, Squasi PAM, Olivari Z (2017) In vitro validation of the lesion size index to predict lesion width and depth after irrigated radiofrequency ablation in a porcine model. JACC Clin Electrophysiol 3(10):1126–1135CrossRef
Metadaten
Titel
Lesion size and adjacent tissue damage assessment with high power and short duration radiofrequency ablation: comparison to conventional radiofrequency ablation power setting
verfasst von
Yoshinari Enomoto
Keijiro Nakamura
Rina Ishii
Yasutake Toyoda
Masako Asami
Takahito Takagi
Hikari Hashimoto
Hidehiko Hara
Kaoru Sugi
Masao Moroi
Masato Nakamura
Publikationsdatum
19.03.2021
Verlag
Springer Japan
Erschienen in
Heart and Vessels / Ausgabe 9/2021
Print ISSN: 0910-8327
Elektronische ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-021-01833-y

Weitere Artikel der Ausgabe 9/2021

Heart and Vessels 9/2021 Zur Ausgabe

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.